SEI Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.8M | Buy |
147,270
+36,870
| +33% | +$6.44M | 0.03% | 653 |
|
|
2025
Q4 | $18.8M | Buy |
110,400
+10,144
| +10% | +$1.56M | 0.02% | 769 |
|
|
2025
Q3 | $13.2M | Buy |
100,256
+16,311
| +19% | +$1.96M | 0.01% | 896 |
|
|
2025
Q2 | $8.91M | Buy |
83,945
+17,088
| +26% | +$1.86M | 0.01% | 1031 |
|
|
2025
Q1 | $8.3M | Buy |
66,857
+5,636
| +9% | +$735K | 0.01% | 1049 |
|
|
2024
Q4 | $7.54M | Sell |
61,221
-26,878
| -31% | -$3.17M | 0.01% | 1109 |
|
|
2024
Q3 | $11.2M | Buy |
88,099
+18,834
| +27% | +$2.06M | 0.01% | 939 |
|
|
2024
Q2 | $8.73M | Buy |
69,265
+26,232
| +61% | +$2.88M | 0.01% | 985 |
|
|
2024
Q1 | $5.36M | Sell |
43,033
-548
| -1% | -$67.1K | 0.01% | 1179 |
|
|
2023
Q4 | $5.6M | Buy |
43,581
+3,768
| +9% | +$470K | 0.01% | 1135 |
|
|
2023
Q3 | $5.16M | Sell |
39,813
-9,714
| -20% | -$1.29M | 0.01% | 1149 |
|
|
2023
Q2 | $6.14M | Sell |
49,527
-5,545
| -10% | -$746K | 0.01% | 1101 |
|
|
2023
Q1 | $8.06M | Sell |
55,072
-2,356
| -4% | -$348K | 0.02% | 965 |
|
|
2022
Q4 | $9.15M | Buy |
57,428
+7,975
| +16% | +$1.17M | 0.02% | 767 |
|
|
2022
Q3 | $6.59M | Sell |
49,453
-2,273
| -4% | -$346K | 0.01% | 953 |
|
|
2022
Q2 | $7.97M | Buy |
51,726
+1,986
| +4% | +$306K | 0.02% | 870 |
|
|
2022
Q1 | $7.64M | Sell |
49,740
-2,700
| -5% | -$392K | 0.02% | 892 |
|
|
2021
Q4 | $6.7M | Buy |
52,440
+1,755
| +3% | +$231K | 0.01% | 983 |
|
|
2021
Q3 | $6.62M | Sell |
50,685
-12,960
| -20% | -$1.96M | 0.01% | 951 |
|
|
2021
Q2 | $11.5M | Buy |
63,645
+18,220
| +40% | +$3.16M | 0.03% | 653 |
|
|
2021
Q1 | $7.64M | Sell |
45,425
-10,574
| -19% | -$1.74M | 0.02% | 797 |
|
|
2020
Q4 | $9.41M | Sell |
55,999
-9,634
| -15% | -$1.43M | 0.02% | 663 |
|
|
2020
Q3 | $9.4M | Buy |
65,633
+3,703
| +6% | +$459K | 0.03% | 568 |
|
|
2020
Q2 | $6.8M | Buy |
61,930
+6,108
| +11% | +$675K | 0.02% | 717 |
|
|
2020
Q1 | $5.59M | Sell |
55,822
-10,706
| -16% | -$1.38M | 0.02% | 699 |
|
|
2019
Q4 | $9.92M | Buy |
66,528
+7,589
| +13% | +$1.03M | 0.03% | 589 |
|
|
2019
Q3 | $7.65M | Sell |
58,939
-2,708
| -4% | -$363K | 0.02% | 723 |
|
|
2019
Q2 | $8.81M | Buy |
61,647
+31,168
| +102% | +$4.19M | 0.03% | 632 |
|
|
2019
Q1 | $4.36M | Buy |
30,479
+14,331
| +89% | +$1.87M | 0.01% | 980 |
|
|
2018
Q4 | $2.45M | Buy |
16,148
+5,077
| +46% | +$753K | 0.01% | 1225 |
|
|
2018
Q3 | $1.88M | Sell |
11,071
-556
| -5% | -$95.6K | 0.01% | 1284 |
|
|
2018
Q2 | $2M | Buy |
11,627
+1,929
| +20% | +$315K | 0.01% | 1326 |
|
|
2018
Q1 | $1.46M | Buy |
9,698
+4,185
| +76% | +$614K | 0.01% | 1318 |
|
|
2017
Q4 | $742K | Sell |
5,513
-4,905
| -47% | -$680K | ﹤0.01% | 1568 |
|
|
2017
Q3 | $1.52M | Buy |
10,418
+5,711
| +121% | +$864K | 0.01% | 1318 |
|
|
2017
Q2 | $733K | Sell |
4,707
-6,020
| -56% | -$921K | ﹤0.01% | 1520 |
|
|
2017
Q1 | $1.56M | Buy |
10,727
+10,137
| +1,718% | +$1.32M | 0.01% | 1238 |
|
|
2016
Q4 | $64K | Sell |
590
-4,867
| -89% | -$542K | ﹤0.01% | 2084 |
|
|
2016
Q3 | $663K | Sell |
5,457
-1,594
| -23% | -$215K | ﹤0.01% | 1390 |
|
|
2016
Q2 | $996K | Buy |
7,051
+168
| +2% | +$24.8K | 0.01% | 1175 |
|
|
2016
Q1 | $898K | Sell |
6,883
-2,222
| -24% | -$277K | 0.01% | 1169 |
|
|
2015
Q4 | $1.28M | Sell |
9,105
-9,840
| -52% | -$1.36M | 0.01% | 1144 |
|
|
2015
Q3 | $2.52M | Sell |
18,945
-4,521
| -19% | -$778K | 0.02% | 700 |
|
|
2015
Q2 | $4.13M | Buy |
23,466
+3,577
| +18% | +$642K | 0.04% | 523 |
|
|
2015
Q1 | $3.44M | Buy |
19,889
+1,687
| +9% | +$290K | 0.03% | 565 |
|
|
2014
Q4 | $2.98M | Buy |
+18,202
| New | +$3.02M | 0.03% | 571 |
|
Other funds holding JAZZ
VPM
VCM
EC
SEI Investments's JAZZ Position: Q1 2026 in Review
SEI Investments increased its Jazz Pharmaceuticals (JAZZ) stake by 33% in Q1 2026, buying an estimated $6.44M and bringing the position to 147,270 shares worth $27.8M. The position accounts for 0.03% of the portfolio, ranked #653.
SEI Investments first reported a position in JAZZ in Q4 2014 and has held it in 46 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- SEI Investments held 147,270 shares of Jazz Pharmaceuticals worth $27.8M as of Q1 2026.
- SEI Investments bought 36,870 Jazz Pharmaceuticals shares in Q1 2026, an estimated $6.44M.
- Jazz Pharmaceuticals made up 0.03% of SEI Investments's portfolio in Q1 2026, its #653 holding.
- SEI Investments first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 46 quarters since.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.